| Status: Under consideration by AWMSG Scrutiny Panel | |
For the off label treatment of moderate to severe hidradenitis suppurativa that does not respond to licensed treatment or where licensed treatments are contraindicated. |
|
Medicine details |
|
| Medicine name | infliximab |
| Formulation | intravenous infusion |
| Reference number | 10020 |
| Indication | As above |
| Company | various |
| BNF chapter | Skin |
| Assessment type | Under consideration |
| Status | Under consideration by AWMSG Scrutiny Panel |